| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Paul Greengard | Q309979 |
| Angus C. Nairn | Q37621746 | ||
| P2093 | author name string | Sven Ivar Walaas | |
| Hugh Caroll Hemmings | |||
| P2860 | cites work | Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons | Q22010952 |
| DARPP-32 mediates the actions of multiple drugs of abuse | Q22241668 | ||
| DARPP-32: regulator of the efficacy of dopaminergic neurotransmission | Q23909380 | ||
| Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice | Q23920781 | ||
| MASTL is the human ortholog of Greatwall kinase that facilitates mitotic entry, anaphase and cytokinesis | Q24298633 | ||
| Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites | Q24304144 | ||
| A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation | Q24305050 | ||
| Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties | Q24312137 | ||
| The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A | Q24317087 | ||
| Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1 | Q24532150 | ||
| Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 | ||
| Neurogenetics and pharmacology of learning, motivation, and cognition | Q24602643 | ||
| Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning | Q24674131 | ||
| Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition | Q24681770 | ||
| Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1 | Q27729832 | ||
| Functional profiling of the Saccharomyces cerevisiae genome | Q27860544 | ||
| Amplification of dopaminergic signaling by a positive feedback loop | Q28142174 | ||
| Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin | Q28202607 | ||
| Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP | Q28215053 | ||
| DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma | Q36625979 | ||
| ERK2: a logical AND gate critical for drug-induced plasticity? | Q36644968 | ||
| Differential expression of protein phosphatase 1 isoforms in mammalian brain. | Q36703761 | ||
| Detailed structural characterization of unbound protein phosphatase 1 inhibitors | Q37105049 | ||
| Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain | Q37113798 | ||
| Phosphorylation of Rap1GAP, a striatally enriched protein, by protein kinase A controls Rap1 activity and dendritic spine morphology | Q37117611 | ||
| Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance | Q37248165 | ||
| Modelling of DARPP-32 regulation to understand intracellular signaling in psychiatric disease. | Q37255845 | ||
| Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs | Q37332784 | ||
| Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs | Q37437347 | ||
| Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia | Q28216472 | ||
| Identification of a dopamine- and 3'5'-cyclic adenosine monophosphate-regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland | Q28236361 | ||
| DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics | Q28244179 | ||
| Coamplified and overexpressed genes at ERBB2 locus in gastric cancer | Q28247481 | ||
| Distribution of DARPP-32 in the basal ganglia: an electron microscopic study | Q28247832 | ||
| Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue | Q28250285 | ||
| Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II | Q28255176 | ||
| DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 | Q28259380 | ||
| DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain | Q28265789 | ||
| Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action | Q28269125 | ||
| Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin | Q28275161 | ||
| Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number | Q28297899 | ||
| The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder | Q28303055 | ||
| Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder | Q28303664 | ||
| DARPP-32 is a robust integrator of dopamine and glutamate signals | Q28469090 | ||
| A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity | Q28472858 | ||
| A phosphatase cascade by which rewarding stimuli control nucleosomal response | Q28508656 | ||
| Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19 | Q28564744 | ||
| Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions | Q28566137 | ||
| Localization of alpha-endosulphine in pancreatic somatostatin delta cells and expression during rat pancreas development | Q28581870 | ||
| Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A | Q28641016 | ||
| A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions | Q28643908 | ||
| Mammalian brain phosphoproteins as substrates for calcineurin | Q28643957 | ||
| A translational profiling approach for the molecular characterization of CNS cell types | Q29615252 | ||
| alpha-Endosulfine is a conserved protein required for oocyte meiotic maturation in Drosophila | Q30486429 | ||
| Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation | Q30498976 | ||
| Quantitative analysis of protein phosphorylation in mouse brain by hypothesis-driven multistage mass spectrometry | Q33229338 | ||
| Conformation-specific binding of alpha-synuclein to novel protein partners detected by phage display and NMR spectroscopy | Q33300201 | ||
| Immunohistochemical evidence for the existence of a dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32) in brown adipose tissue of pigs | Q33672688 | ||
| Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade | Q33703262 | ||
| Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum | Q33723743 | ||
| Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells | Q33743601 | ||
| A dopaminergic gene cluster in the prefrontal cortex predicts performance indicative of general intelligence in genetically heterogeneous mice | Q33754558 | ||
| Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain | Q48432548 | ||
| Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex | Q48492527 | ||
| Bidirectional regulation of DARPP-32 phosphorylation by dopamine. | Q48617260 | ||
| DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus | Q48691482 | ||
| DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. | Q48691508 | ||
| Chronic treatment of rats with SCH-23390 or raclopride does not affect the concentrations of DARPP-32 or its mRNA in dopamine-innervated brain regions | Q48943508 | ||
| Endosulfine, endogenous ligand for the sulphonylurea receptor: isolation from porcine brain and partial structural determination of the alpha form | Q49149470 | ||
| A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. | Q51232410 | ||
| Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2. | Q53556579 | ||
| Backbone 1H, 15N, and 13C resonance assignments of ARPP-19 | Q58111951 | ||
| Phosphorylation of DARPP-32, a Dopamine- and cAMP-regulated Phosphoprotein, by Casein Kinase Iin Vitroandin Vivo | Q58112703 | ||
| Regional distribution of calcium- and cyclic adenosine 3':5'-monophosphate-regulated protein phosphorylation systems in mammalian brain. I. Particulate systems | Q58113987 | ||
| Regional distribution of calcium- and cyclic adenosine 3':5'-monophosphate-regulated protein phosphorylation systems in mammalian brain. II. Soluble systems | Q58114001 | ||
| Study of the conformation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by fluorescence spectroscopy | Q58191998 | ||
| ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Purification and characterization of the protein from bovine caudate nucleus | Q69335204 | ||
| ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain | Q69335209 | ||
| Inhibitors of protein phosphatase-1. Inhibitor-1 of bovine adipose tissue and a dopamine- and cAMP-regulated phosphoprotein of bovine brain are identical | Q69340296 | ||
| ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Amino acid sequence of ARPP-21B from bovine caudate nucleus | Q69357249 | ||
| Development of a dopamine- and cyclic adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation | Q69903096 | ||
| Biochemical evidence for gamma-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat | Q71167470 | ||
| Cell biology. Enforcing the Greatwall in mitosis | Q82920171 | ||
| Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia | Q83756725 | ||
| Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner | Q37448108 | ||
| Protein dynamics and conformational disorder in molecular recognition | Q37544599 | ||
| Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. | Q37600135 | ||
| Multiple receptors for dopamine | Q37876912 | ||
| Protein kinases in the brain | Q38151210 | ||
| Mechanism of inhibition of protein phosphatase 1 by DARPP-32: studies with recombinant DARPP-32 and synthetic peptides | Q38299723 | ||
| Mutation analysis of DARPP-32 as a candidate gene for schizophrenia | Q38312622 | ||
| The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat. | Q39240351 | ||
| DARPP-32 binds to tra2-beta1 and influences alternative splicing. | Q39751893 | ||
| Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers. | Q39870542 | ||
| A second heat-stable protein inhibitor of phosphorylase phosphatase from rabbit muscle | Q39995361 | ||
| Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. | Q40222621 | ||
| The role of dopamine in modulating the structure and function of striatal circuits. | Q40663529 | ||
| Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity | Q41201946 | ||
| Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. | Q41814232 | ||
| Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia | Q42489217 | ||
| The ventral striatopallidal complex: an immunocytochemical analysis of medium-sized striatal neurons and striatopallidal fibers in the basal forebrain of the rat. | Q42491328 | ||
| Localization of ARPP-90, a major 90 kiloDalton basal ganglion-enriched substrate for cyclic AMP-dependent protein kinase, in striatonigral neurons in the rat brain | Q42492921 | ||
| DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution | Q42524859 | ||
| ARPP-21, a cyclic AMP-regulated phosphoprotein (Mr = 21,000) enriched in dopamine-innervated brain regions. Amino acid sequence of the site phosphorylated by cyclic AMP in intact cells and kinetic studies of its phosphorylation in vitro | Q43467798 | ||
| D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. | Q43513203 | ||
| Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder | Q43645946 | ||
| Increased blood pressure and loss of anp-induced natriuresis in mice lacking DARPP-32 gene | Q43691195 | ||
| A novel cyclin provides a link between dopamine and RNA processing | Q43782611 | ||
| Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine | Q44104351 | ||
| An association study between PPP1R1B gene and schizophrenia in the Chinese population | Q44394016 | ||
| Regulation of ania-6 splice variants by distinct signaling pathways in striatal neurons | Q44478504 | ||
| 1H, 15N, and 13C resonance assignments of DARPP-32 (dopamine and cAMP-regulated phosphoprotein, Mr. 32,000)--a protein inhibitor of protein phosphatase-1. | Q44761961 | ||
| A network of control mediated by regulator of calcium/calmodulin-dependent signaling | Q45119454 | ||
| Membrane-induced folding of the cAMP-regulated phosphoprotein endosulfine-alpha | Q46052339 | ||
| Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia | Q46523401 | ||
| Expression of the MAST family of serine/threonine kinases. | Q46799864 | ||
| t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism | Q46805127 | ||
| Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder | Q46869417 | ||
| Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32. | Q46981381 | ||
| Ontogeny of the dopamine and cyclic adenosine-3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system | Q48160244 | ||
| Fifty years of dopamine research | Q48222824 | ||
| Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons | Q48227481 | ||
| DARPP-32 in the ciliary epithelium of the eye: a neurotransmitter-regulated phosphoprotein of brain localizes to secretory cells | Q48285053 | ||
| Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward | Q48298315 | ||
| Dopamine D1 agonist SKF 38393 increases the state of phosphorylation of ARPP-21 in substantia nigra | Q48324414 | ||
| Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen | Q48364102 | ||
| TARPP, a novel protein that accompanies TCR gene rearrangement and thymocyte education | Q48370565 | ||
| DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein. Primary structure and homology with protein phosphatase inhibitor-1. | Q48377963 | ||
| ARPP-39, a membrane-associated substrate for cyclic AMP-dependent protein kinase present in neostriatal neurons | Q48382393 | ||
| Excitatory nature of dopamine in the nigro-caudate pathway | Q48402143 | ||
| Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades | Q33762162 | ||
| Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex | Q33825588 | ||
| Purification and cDNA cloning of ARPP-16, a cAMP-regulated phosphoprotein enriched in basal ganglia, and of a related phosphoprotein, ARPP-19. | Q33910723 | ||
| ARPP-16/ARPP-19: a highly conserved family of cAMP-regulated phosphoproteins | Q33940666 | ||
| Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). | Q34016964 | ||
| DARPP-32 mediates serotonergic neurotransmission in the forebrain | Q34017011 | ||
| Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors | Q34093012 | ||
| Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease. | Q34107415 | ||
| Structural diversity in free and bound states of intrinsically disordered protein phosphatase 1 regulators | Q34116108 | ||
| Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis | Q34155315 | ||
| t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer | Q34156895 | ||
| Cholinergic interneuron characteristics and nicotinic properties in the striatum | Q34159449 | ||
| Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals | Q34276042 | ||
| Diverse psychotomimetics act through a common signaling pathway | Q34278280 | ||
| Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells | Q34313695 | ||
| Alpha endosulfine is a novel molecule, structurally related to a family of phosphoproteins. | Q34387162 | ||
| Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin | Q34492149 | ||
| Molecular investigations of the structure and function of the protein phosphatase 1-spinophilin-inhibitor 2 heterotrimeric complex | Q34579434 | ||
| Dopamine: 50 years in perspective | Q34609657 | ||
| Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission | Q34698478 | ||
| Protein phosphatase 1 regulation by inhibitors and targeting subunits | Q34699609 | ||
| WormBase 2007 | Q34711954 | ||
| Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". | Q34721196 | ||
| DARPP-32 mediates multidrug resistance of gastric cancer through regulation of P-gp and ZNRD1. | Q34721823 | ||
| Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 | ||
| Dopaminergic genes predict individual differences in susceptibility to confirmation bias | Q34994120 | ||
| The extended PP1 toolkit: designed to create specificity | Q35092072 | ||
| DARPP-32: an integrator of neurotransmission | Q35639141 | ||
| Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit | Q35669844 | ||
| The B''/PR72 subunit mediates Ca2+-dependent dephosphorylation of DARPP-32 by protein phosphatase 2A. | Q35834456 | ||
| Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding | Q36101145 | ||
| A mathematical tool for exploring the dynamics of biological networks | Q36288480 | ||
| Cloning of cDNA for DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein | Q36449165 | ||
| Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy. | Q36602125 | ||
| P304 | page(s) | 50 | |
| P577 | publication date | 2011-08-26 | |
| P1433 | published in | Frontiers in Neuroanatomy | Q1893158 |
| P1476 | title | Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases | |
| P478 | volume | 5 |
| Q41784558 | ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase). |
| Q38177261 | Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. |
| Q36499587 | DNA co-methylation modules in postmortem prefrontal cortex tissues of European Australians with alcohol use disorders |
| Q34289262 | Differentially co-expressed genes in postmortem prefrontal cortex of individuals with alcohol use disorders: influence on alcohol metabolism-related pathways |
| Q35848385 | Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats |
| Q37519743 | Feedback regulation mediated by Bcl-2 and DARPP-32 regulates inositol 1,4,5-trisphosphate receptor phosphorylation and promotes cell survival |
| Q50312448 | Genetic variation in dopamine-related gene expression influences motor skill learning in mice |
| Q33112258 | Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution |
| Q38170011 | Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities |
| Q46169409 | Immunohistochemical Localization of DARPP-32 in the Brain of Two Lungfishes: Further Assessment of Its Relationship with the Dopaminergic System |
| Q34200391 | In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function |
| Q41412530 | Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses. |
| Q46168221 | Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats |
| Q36614190 | Marine Ο-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD. |
| Q36956646 | Monozygotic twins affected with major depressive disorder have greater variance in methylation than their unaffected co-twin |
| Q35815966 | Motor Skill Learning Is Associated with Phase-Dependent Modifications in the Striatal cAMP/PKA/DARPP-32 Signaling Pathway in Rodents. |
| Q90258026 | Multidimensional Top-Down Proteomics of Brain-Region-Specific Mouse Brain Proteoforms Responsive to Cocaine and Estradiol |
| Q90428570 | Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target |
| Q27310235 | PPP2R5C Couples Hepatic Glucose and Lipid Homeostasis |
| Q48251648 | Phase imaging with multiple phase-cycled balanced steady-state free precession at 9.4 T. |
| Q39067400 | Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders |
| Q24632495 | Protein phosphatases and Alzheimer's disease |
| Q35880406 | Protein phosphatases and their regulation in the control of mitosis |
| Q38700387 | Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition |
| Q41846304 | Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function |
| Q42111195 | Striatal signaling: two decades of progress. |
| Q58765350 | Sucrose Abstinence and Environmental Enrichment Effects on Mesocorticolimbic DARPP32 in Rats |
| Q90573731 | Targeting Bcl-2-IP3 receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones |
| Q26824764 | The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity |
| Q64083779 | The temporal profile of activity-dependent presynaptic phospho-signalling reveals long-lasting patterns of poststimulus regulation |
| Q89934165 | Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease |
| Q37968513 | Translational genetic approaches to substance use disorders: bridging the gap between mice and humans |
| Q58542293 | cAMP regulation of protein phosphatases PP1 and PP2A in brain |
Search more.